At a glance
ClinicalIndex Comparison RecordN/ACompleted· 575 enrolled
Drug / intervention
Acute Abscess Groupother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Molecular Epidemiology and Phylodynamic and Phylogeographic Analysis of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) Transmission: An Emergency Department Population Sampling Strategy
In Brief
An observational study evaluating Acute Abscess Group for Methicillin-Resistant Staphylococcus Aureus. Completed, enrolled 575 participants across 1 site.
Detailed Summary
Given that the Emergency Department (ED) has become the entry way for large populations of patients into the health care system, a strategy of sampling MRSA isolates in ED populations and merging this information with patient-level data may present a window to hypothesize and investigate CA-MRSA transmission within the community and its impact on hospital-acquired infections.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 2015
Enrollment StartAug 2015
Primary CompletionApr 2018
TodayJul 2026
First PostedFeb 13, 2015
Enrollment StartAug 1, 2015
Primary CompletionApr 4, 2018
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 11.4 years ago
Interventions
Acute Abscess Groupother
Samples collected for culture and sensitivity testing depending on acute abscess, or skin/soft tissue infection.